INTARCIA THERAPEUTICS
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.
INTARCIA THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical Device Personal Health
Founded:
1997-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.intarcia.com
Total Employee:
251+
Status:
Active
Contact:
617-936-2500
Email Addresses:
[email protected]
Total Funding:
1.68 B USD
Technology used in webpage:
Domain Not Resolving Euro IPv6 Amazon Route 53 Microsoft Apple Whitelist
Similar Organizations
Advanced Animal Diagnostics
Advanced Animal Diagnostics develops diagnostic products to cure on-farm animal diseases.
Aerin Medical
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Alcresta
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
American Renal Associates Holdings
American Renal Associates Holdings operates kidney dialysis services and offers outpatient and inpatient dialysis treatments.
Ancora Heart
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
SpaceOAR
SpaceOAR is a medical device company that develops space-filling hydrogels for radiation oncology and cancer surgery indications.
Binx Health
Binx Health creates new categories of healthcare solutions that deliver on-demand testing to people where they need it most.
Butterfly Network
Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Daktari Diagnostics
Daktari Diagnostics manufactures diagnostic medical products for clinicians and patients.
Elcelyx Therapeutics
Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.
Enzium
Enzium develops fluorescent based reagents for selective protease.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Forward
Forward is a healthcare startup that provides a membership-based health care system.
Humacyte
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
ImaginAb
ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Impliant
Impliant, Inc. develops novel spine arthroplasty solutions for motion preservation. The company offers TOPS system.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
iPierian
iPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s.
Ivantis
Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.
jCyte
jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa.
Moximed
Moximed improves the standard of care for patients with osteoarthritis and investigates therapies to treat affected joints.
Opus Genetics
Opus Genetics is a gene therapy company for ultra-rare blinding conditions.
Oxford Immunotec
Oxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Prima Temp
Prima Temp specializes in fertility detection, early disease detection, and circadian rhythm monitoring.
Amelia Virtual Care
Amelia Virtual Care develops a virtual reality platform designed to bring value to mental health treatment.
CardiacSense
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and non-inflating blood pressure monitoring
Syndevrx
SynDevRx develops polymer-based drug conjugates for small molecule drug activity.
UE LifeSciences
UE LifeSciences is a female technology company building preventive oncology solutions for primary care and home.
Unicycive Therapeutics
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs.
Aspira Women's Health
Aspira Women's Health develops and commercializes diagnostic tests that address unmet needs in gynecologic oncology and women’s health.
Know Labs
Know Labs is a non-invasive diagnostic technology platform that uses radio waves to identify and measure molecules in the body.
Vivos Therapeutics
Vivos Therapeutics is a research and development company providing training for health care allowing to integrate breathing wellness.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2015-09-24 | Phoundry Pharmaceuticals | Phoundry Pharmaceuticals acquired by Intarcia Therapeutics | N/A |
Investors List
GGV Capital
GGV Capital investment in Venture Round - Intarcia Therapeutics
SharesPost Investment Management
SharesPost Investment Management investment in Secondary Market - Intarcia Therapeutics
GWC Innovator Fund
GWC Innovator Fund investment in Series E - Intarcia Therapeutics
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Series E - Intarcia Therapeutics
The Pritzker Organization
The Pritzker Organization investment in Series E - Intarcia Therapeutics
Foresite Capital
Foresite Capital investment in Series E - Intarcia Therapeutics
The Baupost Group
The Baupost Group investment in Series E - Intarcia Therapeutics
RA Capital Management
RA Capital Management investment in Series E - Intarcia Therapeutics
Baillie Gifford
Baillie Gifford investment in Series E - Intarcia Therapeutics
Kayon Partners
Kayon Partners investment in Series E - Intarcia Therapeutics
Official Site Inspections
http://www.intarcia.com
- Host name: ec2-18-208-125-27.compute-1.amazonaws.com
- IP address: 18.208.125.27
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149